Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-25
1990-06-12
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546277, C07D41304, A61K 3144
Patent
active
049333534
ABSTRACT:
New piperidine compounds having the formula ##STR1## wherein at least one of R.sup.3, R.sup.4, and R.sup.5 are ##STR2## and the other independently are H, C.sub.1-6 -alkyl, wherein R' is H, C.sub.1-8 -alkyl, phenyl, thienyl, cyclopropyl, or C.sub.1-3 -alkoxymethyl; and
REFERENCES:
Iverson, L. L.: The Cholinergic Hypothesis of Dementia. Trends in Pharmacological Sciences, pp. 44-45, (1986).
Palacios, J. M. et al.: Mapping of Subtypes of Muscarinic Receptors in the Human Brain with Receptor Autoradiographic Techniques. Trends in Pharmacological Sciences, pp. 56-60, (1986).
Smith, C. J. et al.: Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders, J. Neurochem., vol. 50 (3), pp. 847-855, (1988).
The Hydrophobic Fragmental Constant by Rekker, vol. 1 of Pharmaco Chemistry Library by Elsevier Scientific Publishing Company, (1977), pp. 78, 48, 119, 113-117.
Jensen Leif H.
Kindtler Jens W.
Sauerberg Per
Watjen Frank
A/S Ferrosan
Fan Jane T.
Hueschen Gordon W.
LandOfFree
Lipophilically-substituted piperidine oxadiazolyl compounds and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipophilically-substituted piperidine oxadiazolyl compounds and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipophilically-substituted piperidine oxadiazolyl compounds and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-617498